Thrombosis
Conference Coverage
STS: Minimizing LVAD pump thrombosis poses new challenges
News
SNPs may double risk of VTE in African Americans
Photo courtesy of NIGMS Researchers say they have identified 3 genetic variants that may double the risk of venous thromboembolism (VTE) in...
News
Drug could aid standard care for aTTP
The agent, caplacizumab, is an anti-von Willebrand factor, humanized, single-variable-domain immunoglobulin that works by inhibiting the...
News
Caplacizumab induces rapid resolution of acute TTP
Caplacizumab induces faster resolution of acute episodes of acquired thrombotic thrombocytopenic purpura than does conventional therapy by...
News
Method could improve diagnosis of platelet disorders
Courtesy of Dan Cutler A proof-of-concept study suggests structured illumination microscopy (SIM) enables accurate diagnosis of Hermansky-Pudlak...
News
Rivaroxaban trial results hold up, EMA says
The European Medicines Agency (EMA) has concluded that a defect discovered in a system used to measure international normalized ratios (INRs) in...
News
New ROCKET-AF review claims faulty INR monitoring device didn’t affect results
News
Journal questions results of rivaroxaban trial
An investigation by The BMJ has called into question the validity of the ROCKET AF trial, which was used to support approval for the direct oral...
News
EHA creates ‘roadmap’ for hematology research
Photo by Daniel Sone The European Hematology Association (EHA) has created a “roadmap” for hematology research in Europe. This guidance document...
News
ISTH releases new clinical core curriculum
Image by Kevin MacKenzie The International Society on Thrombosis and Haemostasis (ISTH) has announced its new international clinical core...
News
Antiplatelet drug appears effective for women
while another doctor looks on Photo courtesy of NCI An analysis of data from the CHAMPION PHOENIX trial suggests cangrelor is more effective than...